This topic contains a solution. Click here to go to the answer

Author Question: When banks add new services during the maturity stage, the objective they are most likely trying to ... (Read 27 times)

Zoey63294

  • Hero Member
  • *****
  • Posts: 539
When banks add new services during the maturity stage, the objective they are most likely trying to achieve is
 A) pruning items from the product line.
  B) generating cash flow.
  C) maintaining their market share.
  D) filling geographic gaps.
  E) increasing their market share.

Question 2

Sales promotion objectives should be consistent with the organization's overall objectives and its marketing objectives.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Brenm

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

E

Answer to Question 2

True




Zoey63294

  • Member
  • Posts: 539
Reply 2 on: Jun 29, 2018
Thanks for the timely response, appreciate it


vickyvicksss

  • Member
  • Posts: 351
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library